Alexion's Acquisition of Synageva
Scroll to keep reading
Matthew Hurd, Legal counsel to Synageva
Alexion Pharmaceuticals will buy rival Synageva BioPharma in an $8.4 billion cash-and-stock deal that will bolster Alexion’s business in treatments for rare diseases.
Alexion’s takeover offer is aggressive: It will pay $115 in cash and 0.6581 Alexion shares for each share of Synageva, amounting to $230 in cash and stock.
InnovationKong In, the leading developer of cloud API technologies, unveiled during the company’s annual API Summit, its new Premium Technology Partner Programme.
LeadershipCisive is a global provider of compliance-driven human capital management and risk management solutions. Its expert team understands the risks and regulations that apply to the financial services, healthcare, transportation, and other highly regulated industri
LegalFamily disputes can escalate quickly, especially when emotions are high and communication has broken down. Early mediation offers a way to address issues before positions harden and legal costs rise. It provides a structured setting where both parties can spea
NewsChoosing to become a funded trader or sole trader, can affect your journey in the financial market, what type of opportunities are presented to you, and your ability to take advantage of them. Each option has its fair share of pros and cons, and deciding which
FinanceBaker Tilly Isle of Man are a part of Baker Tilly International which is the 7th largest advisory company, and are a leading firm of chartered accountants and business consultants.
LegalDisability-related tribunal cases have increased 133% over the past five years, making it the second most prevalent type of workplace discrimination, new research shows.
NewsEven today, the bulk of commercial transportation takes place via roads. In the US, there’s an estimate that about 70% of products get delivered by trucks. Therefore, starting a box truck company is a lucrative idea in 2023.
InnovationGlobalCare Clinical Trials brings over 100 years of experience in the clinical trials and home healthcare industries supporting over 400 studies in over 50 countries by effectively delivering high quality and convenient clinical trial services in the home or a
NewsArtificial intelligence (AI) holds masses of potential for business optimisation. It can support efficiency and productivity across the board.
Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.
